Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marwan Fakih

Showing results (11-20 of 200) with videos related to

Pageof 20
Sort By:
Oncology (Williston Park, N.Y.)|February 7, 2008
Management of anti-EGFR-targeting monoclonal antibody-induced hypomagnesemiaMarwan Fakih
Oncology (Williston Park, N.Y.)|March 28, 2009
Treating rectal cancer: key issues reconsideredMarwan Fakih
Journal of Gastrointestinal Oncology|July 20, 2012
Predictive or non-predictive, prognostic or non-prognostic: Dilemmas generated through small retrospective studiesMarwan Fakih
Current Oncology Reports|February 14, 2021
Targeting KRAS in Colorectal CancerChongkai Wang, Marwan Fakih
Journal of the National Comprehensive Cancer Network : JNCCN|July 2, 2021
Response to Trastuzumab and Lapatinib in a Metastatic Colorectal Cancer Harboring HER2 Amplification and HER2 S310F MutationChongkai Wang, Marwan Fakih
Journal of Gastrointestinal Oncology|November 18, 2024
The role of negative hyperselection in metastatic colorectal cancerJingran Ji, Marwan Fakih
Expert Opinion on Biological Therapy|May 25, 2021
Targeting MSS colorectal cancer with immunotherapy: are we turning the corner?Chongkai Wang, Marwan Fakih
Anticancer Research|April 19, 2011
First-line cisplatin plus etoposide in high-grade metastatic neuroendocrine tumors of colon and rectum (MCRC NET): review of 8 casesAnnie Patta, Marwan Fakih
Journal of Gastrointestinal Oncology|March 21, 2025
Response to anti-EGFR therapy in chemo-refractory right-sided RAS wild-type metastatic colorectal cancer: a case report and literature reviewAnnie Xiao, Marwan Fakih
Clinical Colorectal Cancer|June 2, 2024
KRAS G12C Inhibitors in the Treatment of Metastatic Colorectal CancerAnnie Xiao, Marwan Fakih
Pageof 20

Showing results (11-20 of 200) with videos related to

Sort By:
Pageof 20
Oncology (Williston Park, N.Y.)|February 7, 2008
Management of anti-EGFR-targeting monoclonal antibody-induced hypomagnesemiaMarwan Fakih
Oncology (Williston Park, N.Y.)|March 28, 2009
Treating rectal cancer: key issues reconsideredMarwan Fakih
Journal of Gastrointestinal Oncology|July 20, 2012
Predictive or non-predictive, prognostic or non-prognostic: Dilemmas generated through small retrospective studiesMarwan Fakih
Current Oncology Reports|February 14, 2021
Targeting KRAS in Colorectal CancerChongkai Wang, Marwan Fakih
Journal of the National Comprehensive Cancer Network : JNCCN|July 2, 2021
Response to Trastuzumab and Lapatinib in a Metastatic Colorectal Cancer Harboring HER2 Amplification and HER2 S310F MutationChongkai Wang, Marwan Fakih
Journal of Gastrointestinal Oncology|November 18, 2024
The role of negative hyperselection in metastatic colorectal cancerJingran Ji, Marwan Fakih
Expert Opinion on Biological Therapy|May 25, 2021
Targeting MSS colorectal cancer with immunotherapy: are we turning the corner?Chongkai Wang, Marwan Fakih
Anticancer Research|April 19, 2011
First-line cisplatin plus etoposide in high-grade metastatic neuroendocrine tumors of colon and rectum (MCRC NET): review of 8 casesAnnie Patta, Marwan Fakih
Journal of Gastrointestinal Oncology|March 21, 2025
Response to anti-EGFR therapy in chemo-refractory right-sided RAS wild-type metastatic colorectal cancer: a case report and literature reviewAnnie Xiao, Marwan Fakih
Clinical Colorectal Cancer|June 2, 2024
KRAS G12C Inhibitors in the Treatment of Metastatic Colorectal CancerAnnie Xiao, Marwan Fakih
Pageof 20